# US 2014/0227736 A1 · Methods and materials for obtaining induced pluripotent stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0227736 A1
- Document ID: US20140227736A1
- Status: Published application
- Kind: A1
- Application number: 14/239,980
- Filed: 2012-08-21
- Published: 2014-08-14
- Earliest claimed: 2011-08-22
- Assignees: Mayo Foundation for Medical Education and Research
- Inventors: Timothy J. Nelson; Andre Terzic; Almudena J. Martinez Fernandez; Clifford D. Folmes
- Web page: https://patentgrep.com/patent/US20140227736A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N 2500/34: Sugars
- C12N 2501/602: Sox-2
- C12N 2501/603: Oct-3/4
- C12N 2501/604: Klf-4
- C12N 2501/606: c-Myc
- C12N 2506/00: Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N 2506/1307: from adult fibroblasts
- C12N 2510/00: Genetically modified cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

This document provides methods and materials involved obtaining induced pluripotent stem (iPS) cells. For example, methods and materials for increasing the efficiency for making iPS cells as well as methods and materials for selecting iPS cells are provided.

## Claims

### Claim 1

A method for augmenting production of induced pluripotent stem cells being produced from somatic cells by the expression of stemness transcription factors, wherein said method comprises contacting said somatic cells with an effective amount of an agent that promotes or aids glycolysis.

### Claim 2 (depends on 1)

The method of claim 1, wherein said somatic cells are fibroblasts.

### Claim 3 (depends on 1)

The method of claim 1, wherein said sternness transcription factors are OCT3/4, SOX2, KLF4, or c-MYC.

### Claim 4 (depends on 1)

The method of claim 1, wherein said sternness transcription factors are OCT3/4, SOX2, and KLF4.

### Claim 5 (depends on 1)

The method of claim 1, wherein said agent is glucose.

### Claim 6 (depends on 1)

The method of claim 1, wherein said agent is glucose, and said effective amount is between 5 mM and 25 mM.

### Claim 7

A method for identifying induced pluripotent stem cells within a sample comprising a mixture of somatic cells and said induced pluripotent stem cells, wherein said method comprises:
(a) contacting said sample with a marker of glycolysis, wherein said marker labels said induced pluripotent stem cells to a greater extent than said somatic cells, and
(b) obtaining said induced pluripotent stem cells from said mixture based at least in part on an increased level of said marker being associated with said induced pluripotent stem cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein said sample is an in vitro culture sample.

### Claim 9 (depends on 7)

The method of claim 7, wherein said somatic cells are fibroblasts.

### Claim 10 (depends on 7)

The method of claim 7, wherein said induced pluripotent stem cells were produced from said somatic cells by the expression of sternness transcription factors.

### Claim at position 11

11-12. (canceled)

### Claim 13 (depends on 7)

The method of claim 7, wherein said induced pluripotent stem cells were produced in the presence of an effective amount of an agent that promotes or aids glycolysis.

### Claim 14 (depends on 13)

The method of claim 13, wherein said agent is glucose.

### Claim 15 (depends on 13)

The method of claim 13, wherein said agent is glucose, and said effective amount is between 5 mM and 25 mM.

### Claim 16 (depends on 7)

The method of claim 7, wherein said marker is lactate.

### Claim 17

A method for identifying induced pluripotent stem cells within a sample comprising a mixture of somatic cells and said induced pluripotent stem cells, wherein said method comprises:
(a) contacting said sample with a marker of mitochondrial membrane potential, wherein said marker labels said induced pluripotent stem cells to a greater extent than said somatic cells, and
(b) obtaining said induced pluripotent stem cells from said mixture based at least in part on an increased level of said marker being associated with said induced pluripotent stem cells.

### Claim 18 (depends on 17)

The method of claim 17, wherein said sample is an in vitro culture sample.

### Claim at position 18

19-22. (canceled)

### Claim 23 (depends on 17)

The method of claim 17, wherein said induced pluripotent stem cells were produced in the presence of an effective amount of an agent that promotes or aids glycolysis.

### Claim 24 (depends on 23)

The method of claim 23, wherein said agent is glucose.

### Claim 25 (depends on 23)

The method of claim 23, wherein said agent is glucose, and said effective amount is between 5 mM and 25 mM.

### Claim 26 (depends on 17)

The method of claim 17, wherein said marker is tetramethylrhodamine methyl ester or 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide.
